Development of Clarstatin, a Novel Drug Lead for the Therapy of Autoimmune Uveitis
We describe the design, synthesis, and activity of a potent thiourea-bridged backbone cyclic peptidomimetic known as Clarstatin, comprising a 5-amino acid sequence (Q/D)<sup>1</sup>-(R/K)<sup>2</sup>-X<sup>3</sup>-X<sup>4</sup>-A<sup>5</sup>-(Gln/Asp)<sup>1</sup>-(Arg/Lys)<sup>2</sup>-AA<sup>3</sup>...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2024-05-01
|
| Серія: | Pharmaceutics |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/1999-4923/16/6/723 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
